References
- He J, Chen WQ, Li ZS, Li N, Ren JS, Tian JH, et al. [China guideline for the screening, early detection and early treatment of esophageal cancer (2022, Beijing)]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022; 44: 491-522. doi: 10.3760/cma.j.cn112152-20220517-00348
- Li S, Chen H, Man J, Zhang T, Yin X, He Q, et al. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med 2021; 10: 1889-99. doi: 10.1002/cam4.3775
- Early Diagnosis and treatment group of the Chinese Medical Association Oncology Branch. [Chinese expert consensus on early diagnosis and treatment of esophageal cancer]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2022; 44: 1066-75. doi: 10.3760/cma.j.cn112152-20220220-00114
- National Health Commission of the People’s Republic of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018. Chin J Cancer Res 2019; 31: 223-58. doi: 10.21147/j.issn.1000-9604.2019.02.01
- Shi Z, Zhu X, Ruan C, Wei G, Li J, Qiu H, et al. Evaluation of concurrent chemoradiotherapy for survival outcomes in patients with synchronous oligometastatic esophageal squamous cell carcinoma. JAMA Netw Open 2022; 5: e2244619. doi: 10.1001/jamanetworkopen.2022.44619
- Luo D, Zhong Q, Yue H, Wang J, Liang Q, Liu W, et al. The predictors of lymphopenia and its effects on survival in locally advanced esophageal squamous cell carcinoma. Cancer Biol Ther 2024; 25: 2371632. doi: 10.1080/15384047.2024.2371632
- Cinicola J, Mamidanna S, Yegya-Raman N, Spencer K, Deek MP, Jabbour SK. A review of advances in radiotherapy in the setting of esophageal cancers. Surg Oncol Clin N Am 2023; 32: 433-59. doi: 10.1016/j.soc.2023.03.004
- Wang X, Wang P, Huang X, Han Y, Zhang P. Biomarkers for immunotherapy in esophageal cancer. Front Immunol 2023; 14: 1117523. doi: 10.3389/fimmu.2023.1117523
- Suzuki R, Lin SH, Wei X, Allen PK, Welsh JW, Byers LA, et al. Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer. Radiother Oncol 2018; 126: 499-505. doi: 10.1016/j.radonc.2017.12.030
- Cox S, Hurt C, Grenader T, Mukherjee S, Bridgewater J, Crosby T. The prognostic value of derived neutrophil to lymphocyte ratio in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 2017; 125: 154-9. doi: 10.1016/j.radonc.2017.08.023
- Huang D, Zhu XZ, Sheng WQ. [2019 updates of the WHO classification of the digestive system tumors, part: epithelial neoplasms in gastrointestinal tract]. [Chinese]. Zhonghua Bing Li Xue Za Zhi 2020; 49: 209-13. doi: 10.3760/cma.j.issn.0529-5807.2020.03.001
- World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-4. doi: 10.1001/jama.2013.281053
- Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-47. doi: 10.1016/j.ejca.2008.10.026
- Wang H, Lan L, Chen J, Xiao L, Han F. Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients. Lupus Sci Med 2022; 9: e000717. doi:10.1136/lupus-2022-000717
- Khan J, Lieberman JA, Lockwood CM. Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs. Clin Chem Lab Med 2017; 55: 608-21. doi: 10.1515/cclm-2016-0471
- Zegels G, Van Raemdonck GA, Tjalma WA, Van Ostade XW. Use of cervicov-aginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci 2010; 8: 63. doi: 10.1186/1477-5956-8-63
- Pleil JD, Wallace MAG, Stiegel MA, Funk WE. Human biomarker interpretation: the importance of intra-class correlation coefficients (ICC) and their calculations based on mixed models, ANOVA, and variance estimates. J Toxicol Environ Health B Crit Rev 2018; 21: 161-80. doi: 10.1080/10937404.2018.1490128
- Zhang J, Dasgupta A, Ayala R, Bonapace C, Kassim S, Faustino PJ. Internal standard variability: root cause investigation, parallelism for evaluating trackability and practical considerations. Bioanalysis 2024; 16: 771-6. doi: 10.1080/17576180.2024.2348939
- Shao N, Cai Q. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol 2015; 17: 772-8. doi: 10.1007/s12094-015-1289-8
- Shao B, Li H, Liu X, Song G, Jiang H, Yan Y, et al. The prognostic value of neu-trophil-to-lymphocyte ratio in de novo stage IV breast cancer: a retrospective cohort study. Ann Transl Med 2023; 11: 45. doi: 10.21037/atm-22-5612